144 related articles for article (PubMed ID: 11298625)
21. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
[TBL] [Abstract][Full Text] [Related]
22. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
Klugbauer S; Lengfelder E; Demidchik EP; Rabes HM
Oncogene; 1995 Dec; 11(12):2459-67. PubMed ID: 8545102
[TBL] [Abstract][Full Text] [Related]
23. Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.
Namba H; Yamashita S; Pei HC; Ishikawa N; Villadolid MC; Tominaga T; Kimura H; Tsuruta M; Yokoyama N; Izumi M
Endocrinol Jpn; 1991 Dec; 38(6):627-32. PubMed ID: 1823030
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation.
Bounacer A; Wicker R; Caillou B; Cailleux AF; Sarasin A; Schlumberger M; Suárez HG
Oncogene; 1997 Sep; 15(11):1263-73. PubMed ID: 9315093
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
[TBL] [Abstract][Full Text] [Related]
26. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro M; Carlomagno F; Hay ID; Herrmann MA; Grieco M; Melillo R; Pierotti MA; Bongarzone I; Della Porta G; Berger N
J Clin Invest; 1992 May; 89(5):1517-22. PubMed ID: 1569189
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas.
Lam KY; Lo CY; Leung PS
Eur J Endocrinol; 2002 Dec; 147(6):741-5. PubMed ID: 12457448
[TBL] [Abstract][Full Text] [Related]
28. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation.
Mizuno T; Iwamoto KS; Kyoizumi S; Nagamura H; Shinohara T; Koyama K; Seyama T; Hamatani K
Oncogene; 2000 Jan; 19(3):438-43. PubMed ID: 10656692
[TBL] [Abstract][Full Text] [Related]
29. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH.
Cinti R; Yin L; Ilc K; Berger N; Basolo F; Cuccato S; Giannini R; Torre G; Miccoli P; Amati P; Romeo G; Corvi R
Cytogenet Cell Genet; 2000; 88(1-2):56-61. PubMed ID: 10773666
[TBL] [Abstract][Full Text] [Related]
30. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
[TBL] [Abstract][Full Text] [Related]
31. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.
Nikiforov YE; Rowland JM; Bove KE; Monforte-Munoz H; Fagin JA
Cancer Res; 1997 May; 57(9):1690-4. PubMed ID: 9135009
[TBL] [Abstract][Full Text] [Related]
32. RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material.
Williams GH; Rooney S; Thomas GA; Cummins G; Williams ED
Br J Cancer; 1996 Aug; 74(4):585-9. PubMed ID: 8761374
[TBL] [Abstract][Full Text] [Related]
33. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis.
Wirtschafter A; Schmidt R; Rosen D; Kundu N; Santoro M; Fusco A; Multhaupt H; Atkins JP; Rosen MR; Keane WM; Rothstein JL
Laryngoscope; 1997 Jan; 107(1):95-100. PubMed ID: 9001272
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.
Musholt TJ; Musholt PB; Khaladj N; Schulz D; Scheumann GF; Klempnauer J
Surgery; 2000 Dec; 128(6):984-93. PubMed ID: 11114633
[TBL] [Abstract][Full Text] [Related]
35. Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany.
Mayr B; Pötter E; Goretzki P; Rüschoff J; Dietmaier W; Hoang-Vu C; Dralle H; Brabant G
Langenbecks Arch Surg; 1999 Feb; 384(1):54-9. PubMed ID: 10367631
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant.
Thomas GA; Bunnell H; Cook HA; Williams ED; Nerovnya A; Cherstvoy ED; Tronko ND; Bogdanova TI; Chiappetta G; Viglietto G; Pentimalli F; Salvatore G; Fusco A; Santoro M; Vecchio G
J Clin Endocrinol Metab; 1999 Nov; 84(11):4232-8. PubMed ID: 10566678
[TBL] [Abstract][Full Text] [Related]
37. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
[TBL] [Abstract][Full Text] [Related]
38. Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma.
Burgess JR; Skabo S; McArdle K; Tucker P
ANZ J Surg; 2003; 73(1-2):31-5. PubMed ID: 12534735
[TBL] [Abstract][Full Text] [Related]
39. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas.
Jhiang SM; Sagartz JE; Tong Q; Parker-Thornburg J; Capen CC; Cho JY; Xing S; Ledent C
Endocrinology; 1996 Jan; 137(1):375-8. PubMed ID: 8536638
[TBL] [Abstract][Full Text] [Related]
40. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]